Lineage Cell Therapeutics : Prospectus disclosing information, facts, events
Filed Pursuant to Rule 424 Registration No. 333-277758 PROSPECTUS SUPPLEMENT Up to $39,966,424...
Source: marketscreener.com
Page 15 - Genentech News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Genentech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Genentech Today - Breaking & Trending Today
BioNTech SE: BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024
MAINZ, Germany, May 21, 2024 - BioNTech SE(Nasdaq: BNTX, "BioNTech" or "the Company") will present clinical trial data for selected programs from the Company's diversified immuno-oncology pipeline at the
Source: finanznachrichten.de
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024 | Company Announcement
Investegate announcements from BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024
Source: investegate.co.uk
The growing promise of cancer vaccines
No magic bullet is in sight yet, but three vaccines for particular skin and lung cancer types have advanced to the last phase of clinical trials.
Source: theweek.in
Lineage Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium
Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced updates to its 2nd Annual Spinal Cord Injury Investor Symposium ("2nd SCIIS"). The 2nd SCIIS aims...
Source: lelezard.com